A phase II trial of conversion surgery after induction chemotherapy(Gemcitabine+nab-Paclitaxel) and chemoradiotherapy(RT+S-1) for the patients with locally advanced pancreatic cancer.
Phase 2
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000023217
- Lead Sponsor
- Ochanomizu Gastrointestinal Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
Not provided
Exclusion Criteria
1)-1 Initially diagnosed as resectable pancreatic cancer -2 Initially diagnosed as unresectable pancreatic cancer with distant metastasis 2)Age: over 80 years, or less than 20 years 3)ECOG performance status =>2 4)Previous treatments 5)Labodata do not satisfy inclusion criteria 6)No written informed consent 7)Inadequate physical condition, as diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The R0 resection rate
- Secondary Outcome Measures
Name Time Method